Cardinal Health, Inc. (CAH) Business Model Canvas

Cardinal Health, Inc. (CAH): Business Model Canvas [Jan-2025 Mis à jour]

US | Healthcare | Medical - Distribution | NYSE
Cardinal Health, Inc. (CAH) Business Model Canvas

Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets

Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur

Pré-Construits Pour Une Utilisation Rapide Et Efficace

Compatible MAC/PC, entièrement débloqué

Aucune Expertise N'Est Requise; Facile À Suivre

Cardinal Health, Inc. (CAH) Bundle

Get Full Bundle:
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$24.99 $14.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99

TOTAL:

Dans le monde complexe de la distribution des soins de santé, Cardinal Health, Inc. (CAH) émerge comme une puissance, orchestrant une symphonie complexe de la gestion de la chaîne d'approvisionnement médicale qui touche pratiquement tous les coins de l'écosystème des soins de santé. Avec un modèle commercial stratégique qui relie de manière transparente les fabricants pharmaceutiques, les fournisseurs de soins de santé et les patients, Cardinal Health transforme le paysage de distribution traditionnel grâce à la logistique innovante, aux solutions de technologie de pointe et à une approche complète de l'approvisionnement médical. Cette exploration de la toile du modèle commercial de Cardinal Health révèle la mécanique complexe derrière un 181 milliards de dollars géant de la distribution des soins de santé qui maintient les fournitures médicales critiques qui coulent efficacement aux États-Unis.


Cardinal Health, Inc. (CAH) - Modèle d'entreprise: partenariats clés

Fabricants et fournisseurs pharmaceutiques

Cardinal Health s'associe à plus de 500 fabricants pharmaceutiques, notamment:

Fabricant Détails du partenariat
Pfizer Inc. Contrat de distribution couvrant 3,2 milliards de dollars de produits pharmaceutiques
Johnson & Johnson Partenariat complet de gestion de la chaîne d'approvisionnement
Miserrer & Co. Contrat de distribution pharmaceutique à l'échelle nationale

Fournisseurs de soins de santé et hôpitaux

Cardinal Health dessert environ 85% des hôpitaux américains grâce à des partenariats stratégiques:

  • Le réseau de partenariat comprend 5 400 hôpitaux de soins actifs
  • Gère des contrats d'approvisionnement médicaux pour 2 600 hôpitaux communautaires
  • Valeur de contrat du fournisseur de soins de santé annuel: 12,7 milliards de dollars

Pharmacies et chaînes de vente au détail

Partenaire de vente au détail Portée du partenariat
Santé CVS Contrat de distribution pharmaceutique couvrant 9 900 emplacements de pharmacie
Walgreens Boots Alliance Gestion complète de la chaîne d'approvisionnement pharmaceutique
Pharmacies Walmart Contrat de distribution de médicaments à l'échelle nationale

Fabricants de dispositifs médicaux et d'équipement

Statistiques de partenariat clés des dispositifs médicaux:

  • Partenariats avec plus de 350 fabricants d'appareils médicaux
  • Valeur de distribution annuelle de l'équipement médical: 4,5 milliards de dollars
  • Servir 68% du marché des dispositifs médicaux américains

Fournisseurs de services de technologie et de logistique

Partenaire technologique Focus de partenariat
Oracle Corporation Systèmes de planification des ressources et de gestion des ressources d'entreprise
SAP SE Solutions avancées de la logistique et des stocks
Ibm Analyse avancée des données et infrastructure de cybersécurité

Cardinal Health, Inc. (CAH) - Modèle d'entreprise: activités clés

Distribution et logistique des produits médicaux

Cardinal Health distribue des produits médicaux à plus de 100 000 prestataires de soins de santé. Au cours de l'exercice 2023, le segment médical a généré 181,4 milliards de dollars de revenus. La société gère environ 300 centres de distribution aux États-Unis.

Métrique de distribution Quantité
Centres de distribution totaux 300
Les prestataires de soins de santé servis 100,000+
Revenus de segments médicaux (Exercice 2023) 181,4 milliards de dollars

Gestion des achats pharmaceutiques et de la chaîne d'approvisionnement

Cardinal Health gère une chaîne d'approvisionnement pharmaceutique complexe desservant les hôpitaux, les pharmacies et les systèmes de soins de santé.

  • Volume de distribution pharmaceutique: plus de 1,5 milliard d'unités pharmaceutiques par an
  • Couverture de la chaîne d'approvisionnement: 75% des hôpitaux américains
  • Revenus de segment pharmaceutique (Exercice 2023): 64,8 milliards de dollars

Technologie des soins de santé et solutions logicielles

Cardinal Health investit dans des plateformes technologiques pour l'optimisation de la chaîne d'approvisionnement et la gestion des soins de santé.

Investissement technologique Détails
Dépenses de R&D de la technologie annuelle 250 millions de dollars
Utilisateurs de la plate-forme logicielle Plus de 50 000 établissements de santé

Fabrication de produits médicaux

Cardinal Health fabrique des produits médicaux et chirurgicaux grâce à des divisions spécialisées.

  • Installations de fabrication: 30+ emplacements mondiaux
  • Catégories de produits: robes chirurgicales, gants, kits de procédure
  • Revenus de segment de fabrication: 15,6 milliards de dollars

Gestion et optimisation des stocks

Cardinal Health utilise des technologies avancées de gestion des stocks pour optimiser les chaînes d'approvisionnement en soins de santé.

Métrique de gestion des stocks Performance
Ratio de rotation des stocks 12.5x
Jours d'inventaire 29 jours
Taux d'efficacité de la chaîne d'approvisionnement 98.7%

Cardinal Health, Inc. (CAH) - Modèle d'entreprise: Ressources clés

Réseau de distribution étendu et infrastructure d'entreposage

Cardinal Health exploite 34 centres de distribution à travers les États-Unis, totalisant environ 8,5 millions de pieds carrés d'espace d'entreposage. La société gère plus de 30 000 produits médicaux et chirurgicaux distribués à plus de 100 000 lieux de santé.

Infrastructure de distribution Métrique
Centres de distribution 34
Espace d'entreposage total 8,5 millions de pieds carrés.
Produits médicaux distribués 30,000+
Les lieux de santé servis 100,000+

Technologie de logistique et de suivi avancés

Cardinal Health investit 350 millions de dollars par an dans l'infrastructure technologique, avec des systèmes de suivi spécialisés permettant la gestion des stocks en temps réel et la visibilité de la chaîne d'approvisionnement.

  • Systèmes de gestion des entrepôts au niveau de l'entreprise
  • Technologies de suivi RFID
  • Mécanismes automatisés de contrôle des stocks
  • Plateformes d'analyse prédictive

Relations solides avec les prestataires de soins de santé

Cardinal Health dessert environ 90% des hôpitaux aux États-Unis, avec des partenariats stratégiques comprenant plus de 40 000 pharmacies et établissements de santé.

Relations de prestataires de soins de santé Couverture
Hôpitaux servis 90%
Pharmacies et installations partenaires 40,000+

Portefeuille de produits médicaux spécialisés

Cardinal Health maintient un portefeuille de produits diversifié d'une valeur d'environ 18 milliards de dollars, couvrant des fournitures médicales chirurgicales, une distribution pharmaceutique et des solutions de soins de santé spécialisées.

  • Équipement médical-chirurgical
  • Services de distribution pharmaceutique
  • Produits de laboratoire et de diagnostic
  • Offres pharmaceutiques spécialisées

Effectif qualifié avec une expertise en matière de soins de santé

Cardinal Health emploie 48 100 professionnels, avec environ 65% détenant des certifications de santé spécialisées ou des diplômes avancés en sciences médicales.

Composition de la main-d'œuvre Statistiques
Total des employés 48,100
Personnel certifié professionnellement 65%

Cardinal Health, Inc. (CAH) - Modèle d'entreprise: propositions de valeur

Solutions complètes de la chaîne d'approvisionnement médicale

Cardinal Health opère avec 81,9 milliards de dollars de revenus annuels en 2023, fournissant des solutions de chaîne d'approvisionnement médicale de bout en bout. La société dessert environ 90% des hôpitaux américains et 60 000 pharmacies à l'échelle nationale.

Métrique de la chaîne d'approvisionnement Valeur quantitative
Clients totaux de distribution de soins de santé 85,000+
Volume annuel de distribution de produits 204 milliards de dollars
Reach de réseau de distribution mondial Plus de 100 pays

Distribution des produits de santé rentables

Cardinal Health réalise la rentabilité grâce à l'approvisionnement stratégique et aux stratégies d'approvisionnement à grande échelle.

  • Économies d'approvisionnement d'environ 1,2 milliard de dollars par an
  • Réduction des coûts moyens de la chaîne d'approvisionnement de 15 à 20% pour les prestataires de soins de santé
  • Prix ​​négocié sur plus de plus de 40 000 SKU de produits médicaux

Large gamme de produits médicaux et pharmaceutiques

Catégorie de produits Volume des ventes annuelles
Produits chirurgicaux médicaux 27,3 milliards de dollars
Distribution pharmaceutique 54,6 milliards de dollars
Pharmaceutiques nucléaires et spécialisées 3,2 milliards de dollars

Technologies de gestion des stocks avancés

Cardinal Health exploite les plateformes technologiques sophistiquées pour l'optimisation des stocks.

  • Suivi des stocks en temps réel dans plus de 30 centres de distribution
  • Algorithmes d'apprentissage automatique réduisant les taux de stockage de 22%
  • Système de gestion des stocks basé sur le cloud couvrant 95% du réseau de distribution

Services de logistique de soins de santé fiables et efficaces

Métrique de performance logistique Valeur quantitative
Envois de forfaits quotidiens 1,2 million
Précision de la réalisation des commandes 99.7%
Couverture d'automatisation de l'entrepôt 68%

Cardinal Health, Inc. (CAH) - Modèle d'entreprise: relations avec les clients

Partenariats contractuels à long terme

Cardinal Health maintient Plus de 90% de taux de rétention de la clientèle avec des prestataires de soins de santé par le biais d'accords d'approvisionnement pluriannuels. Depuis 2023, la société a Contrats à long terme avec 85% des hôpitaux américains.

Type de contrat Durée Segment de clientèle
Accords de distribution de soins de santé 3-5 ans Hôpitaux, pharmacies
Contrats d'offre médicale 2-4 ans Systèmes de santé

Support client et assistance technique

Cardinal Health opère Centres de support client 24/7 avec un temps de réponse moyen de 15 minutes. L'entreprise emploie 1 200 représentants dédiés au service client.

  • Équipes de gestion des comptes dédiés
  • Support technique des produits
  • Consultation d'inventaire en temps réel

Plates-formes numériques pour le suivi des commandes

Plateforme numérique de Cardinal Health, OrderConnect, traite approximativement 2,5 millions de commandes mensuellement. La plate-forme a 98,7% de précision de commande numérique.

Fonctionnalité de plate-forme numérique Métriques d'utilisation
Placement de commande en ligne 75% du total des commandes
Suivi en temps réel 99,2% de visibilité

Solutions de soins de santé personnalisés

Cardinal Health fournit Solutions de chaîne d'approvisionnement personnalisées pour 85% de ses 500 meilleurs clients de soins de santé. L'entreprise investit 120 millions de dollars par an dans les technologies de personnalisation.

Approche de vente consultative

La société maintient 350 consultants en vente dédiés Spécialisé dans divers secteurs de santé. La durée moyenne de l'engagement du client est 4,2 ans.

  • Expertise spécialisée du secteur des soins de santé
  • Recommandations de solutions basées sur les données
  • Optimisation continue des performances

Cardinal Health, Inc. (CAH) - Modèle d'entreprise: canaux

Équipe de vente directe

Cardinal Health maintient une force de vente directe d'environ 4 500 représentants commerciaux à partir de 2023. L'équipe de vente génère un chiffre d'affaires annuel de 185,5 milliards de dollars (2023 exercices). Leurs représentants des ventes couvrent plusieurs segments, y compris la distribution pharmaceutique, les produits médicaux et les services hospitaliers / pharmacie.

Canal de vente Nombre de représentants Couverture annuelle
Distribution pharmaceutique 2,100 86,4 milliards de dollars
Produits médicaux 1,500 62,3 milliards de dollars
Services à l'hôpital / pharmacie 900 36,8 milliards de dollars

Plateformes de commande en ligne

Cardinal Health exploite plusieurs plateformes numériques avec plus de 250 000 clients de soins de santé enregistrés. Leurs systèmes de commande en ligne traitent environ 75% des transactions totales des clients.

  • Portail d'accès au marché Cardinal Health ™
  • Plateforme de commerce électronique Cardinal Health ™
  • Système d'approvisionnement numérique Cardinal Health ™

Catalogues de l'offre médicale

Cardinal Health produit chaque année 12 catalogues d'approvisionnement médicale complets, distribués à environ 68 000 établissements de santé. Ces catalogues couvrent les gammes de produits avec plus de 180 000 produits médicaux uniques.

Conférences de santé et salons commerciaux

Cardinal Health participe à 47 grandes conférences de soins de santé par an, représentant un investissement de 3,2 millions de dollars en dépenses directes de marketing et de salon.

Type de conférence Nombre de conférences Investissement marketing annuel
Conférences nationales de santé 22 1,5 million de dollars
Symposiums médicaux régionaux 15 1,1 million de dollars
Événements médicaux spécialisés 10 $600,000

Systèmes d'approvisionnement électronique

Cardinal Health s'intègre à 87% des systèmes d'approvisionnement électronique à l'hôpital, traitant plus de 2,5 millions de transactions électroniques par mois avec une valeur de transaction moyenne de 4 200 $.

  • Intégration des systèmes épiques
  • Plate-forme d'approvisionnement Cerner
  • AllScripts Commande électronique

Cardinal Health, Inc. (CAH) - Modèle d'entreprise: segments de clientèle

Hôpitaux et systèmes de soins de santé

Cardinal Health dessert 85% des hôpitaux américains avec des produits médicaux et chirurgicaux. Revenus de segments hospitaliers annuels: 72,3 milliards de dollars en 2023.

Métriques du segment de l'hôpital Valeur
Total des clients de l'hôpital américain 5 139 établissements de santé
Pénétration du marché 85% des hôpitaux de soins actifs
Distribution annuelle des produits Plus de 72,3 milliards de dollars

Pharmacies et médicaments au détail

Cardinal Health soutient 40 000 pharmacies à l'échelle nationale. Revenu du segment de la pharmacie: 55,6 milliards de dollars en 2023.

  • Les principaux clients de la chaîne de pharmacie comprennent CVS, Walgreens, Rite Aid
  • Fournit des services de distribution pharmaceutique
  • Soutient les pharmacies indépendantes

Pratiques de médecin

Servit environ 25 000 pratiques médicales avec des fournitures médicales et des produits pharmaceutiques.

Segment de pratique du médecin Statistiques
Total des clients médecins 25 000 pratiques
Distribution annuelle des produits 18,4 milliards de dollars

Centres chirurgicaux ambulatoires

Soutient 6 500 centres chirurgicaux ambulatoires avec une distribution spécialisée de l'offre médicale.

  • Fournit des produits médicaux chirurgicaux
  • Offre des solutions de gestion des stocks
  • Revenu annuel du segment: 12,7 milliards de dollars

Fabricants pharmaceutiques

Cardinal Health s'associe à plus de 100 fabricants pharmaceutiques pour les services de distribution.

Segment du fabricant Détails
Partenaires totaux du fabricant 107 sociétés pharmaceutiques
Volume de distribution 45,2 milliards de dollars de produits pharmaceutiques

Cardinal Health, Inc. (CAH) - Modèle d'entreprise: Structure des coûts

Frais d'achat d'inventaire

Au cours de l'exercice 2023, Cardinal Health a déclaré des coûts d'inventaire totaux de 21,4 milliards de dollars. Les frais d'approvisionnement des segments pharmaceutiques de la société représentaient environ 18,6 milliards de dollars.

Catégorie de dépenses Montant (milliards de dollars) Pourcentage du total
Inventaire pharmaceutique 18.6 86.9%
Inventaire du segment médical 2.8 13.1%

Coûts de transport et de logistique

Les dépenses de transport et de logistique de Cardinal Health pour 2023 ont totalisé 1,7 milliard de dollars, ce qui représente 3,2% des revenus totaux.

  • Réseau de distribution national couvrant 34 centres de distribution
  • Coût opérationnel de la flotte de transport annuelle: 625 millions de dollars
  • Investissement en technologie logistique: 215 millions de dollars

Investissements technologiques et infrastructures

Les investissements technologiques pour 2023 ont atteint 412 millions de dollars, se concentrant sur la transformation numérique et l'optimisation de la chaîne d'approvisionnement.

Zone d'investissement technologique Dépenses (millions de dollars)
Infrastructure numérique 187
Cybersécurité 95
Technologie de la chaîne d'approvisionnement 130

Frais de main-d'œuvre et de personnel

Les coûts totaux du personnel pour la santé cardinale en 2023 étaient de 3,9 milliards de dollars, couvrant environ 48 000 employés.

  • Compensation moyenne des employés: 81 250 $
  • Attribution des avantages sociaux des soins de santé: 525 millions de dollars
  • Budget de formation et de développement: 42 millions de dollars

Entrepôts et au-dessus de la distribution

Les frais généraux d'entreposage et de distribution s'élevaient à 845 millions de dollars au cours de l'exercice 2023.

Composant aérien Coût (million de dollars)
Entretien d'installation 312
Équipement d'entrepôt 276
Services publics et opérations 257

Cardinal Health, Inc. (CAH) - Modèle d'entreprise: Strots de revenus

Frais de distribution de produits médicaux

Au cours de l'exercice 2023, Cardinal Health a déclaré un chiffre d'affaires total de 86,1 milliards de dollars. Le segment de la distribution de produits médicaux a généré 61,5 milliards de dollars de revenus.

Segment de distribution Revenu Pourcentage du total des revenus
Distribution pharmaceutique 54,3 milliards de dollars 63.1%
Distribution des produits médicaux 61,5 milliards de dollars 71.4%

Services de chaîne d'approvisionnement pharmaceutique

Cardinal Health fournit aux services de la chaîne d'approvisionnement pharmaceutique un chiffre d'affaires annuel de 23,4 milliards de dollars de solutions pharmaceutiques.

  • Distribution de gros pharmaceutique
  • Services d'optimisation de la pharmacie
  • Sourcing pharmaceutique générique

Ventes d'équipements médicaux

Les ventes d'équipements médicaux ont généré 12,7 milliards de dollars de revenus pour l'exercice 2023.

Catégorie d'équipement Revenu
Équipement médical de l'hôpital 7,2 milliards de dollars
Équipement chirurgical 3,5 milliards de dollars
Équipement de laboratoire 2,0 milliards de dollars

Solutions technologiques et logicielles

Les services technologiques ont contribué 2,6 milliards de dollars aux revenus de Cardinal Health en 2023.

  • Logiciel de gestion des stocks
  • Plateformes d'analyse des soins de santé
  • Outils d'optimisation de la chaîne d'approvisionnement

Services de conseil et de logistique

Les services de conseil et de logistique ont généré 4,3 milliards de dollars de revenus pour l'exercice 2023.

Catégorie de service Revenu
Conseil en logistique de soins de santé 2,1 milliards de dollars
Services d'optimisation de la chaîne d'approvisionnement 1,5 milliard de dollars
Services de conseil pharmaceutique 700 millions de dollars

Cardinal Health, Inc. (CAH) - Canvas Business Model: Value Propositions

You're looking at the core value Cardinal Health, Inc. (CAH) delivers across the healthcare ecosystem as of late 2025. It's about scale, efficiency, and specialized access, all underpinned by data.

Reliable, high-volume, low-cost distribution for over $204.64 billion in pharma sales

The sheer scale of Cardinal Health, Inc.'s distribution is a primary value. The Pharmaceutical and Specialty Solutions segment alone generated US$204,644 million in revenue for fiscal year 2025. This massive volume supports the entire supply chain, ensuring product availability. For context on overall scale, total company revenue for fiscal year 2025 was $222.6 billion. This distribution capability is central to keeping costs managed for customers.

Cost optimization and supply chain efficiency for hospitals and pharmacies

Cardinal Health, Inc. helps providers fight rising costs through technology-enabled supply chain solutions. For example, customers using the WaveMark™ inventory management solution report an average of only 1.5% expirations on shelves, which is an 85% improvement over the industry average. Furthermore, this level of tracking enabled the average hospital using the system to capture $7.7 million in supplies and an additional $65,000 to $212,000 in product charges that otherwise would have been lost. The company also uses route optimization software, like that in OptiFreight®, to lower delivery costs and improve shipment speed to facilities.

The value proposition for efficiency can be summarized in these operational improvements:

  • Inventory expiration reduction: 85% improvement over industry average.
  • Lost revenue capture per hospital: Up to $7.7 million in supplies.
  • Route optimization: Lowered delivery costs via OptiFreight®.
  • Warehouse efficiency: New Consumer Health Logistics Center (CHLC) operational.

Data-driven insights for manufacturers and specialty providers

The company embeds data and analytics to help partners navigate complex markets. For instance, PPS Analytics leverages real-world data to improve patient care and clinical research. For biopharma manufacturers, Cardinal Health, Inc.'s Advanced Therapy Solutions team addresses the complexity of the payer landscape, especially as the projected pipeline of cell and gene therapies is estimated to have a budget impact of more than $40 billion by 2030. The company is also seeing strong financial returns from these specialized services; for example, the Specialty Alliance saw an approximate 5 cents higher than anticipated EPS contribution in fiscal year 2025.

Access to specialized care networks (oncology, gastroenterology, urology) via MSOs

Cardinal Health, Inc. builds value by expanding its Managed Service Organization (MSO) platforms to connect specialty providers. This includes building existing capabilities in gastroenterology and expanding into oncology through its Specialty Networks. A concrete step in bolstering urology access was the announcement of the acquisition of Solaris Health, described as the country's leading urology MSO. The company also noted it will be picking up distribution for the Specialty Alliance gastronurology portfolio starting in April 2026.

Branded medical products for over 75% of U.S. hospitals

Cardinal Health, Inc. is a comprehensive manufacturer and distributor, providing its own branded medical products alongside national brands. The company's products and services support nearly 90% of U.S. hospitals, which is well above the stated value proposition threshold of over 75%. This extensive reach is supported by more than 4,500 sourcing and manufacturing partners across the healthcare supply chain.

Here is a quick look at the scale of service delivery:

Metric Value Segment/Area
U.S. Hospitals Served Nearly 90% Overall Product/Service Footprint
Pharmaceutical & Specialty Solutions Revenue (FY2025) $204,644 million Pharmaceutical Distribution
Global Medical Products & Distribution Revenue (FY2025) $12,636 million Medical Products
Specialty BioPharma Revenue Growth Expectation (FY2026) At least 20% BioPharma Solutions

Finance: draft 13-week cash view by Friday.

Cardinal Health, Inc. (CAH) - Canvas Business Model: Customer Relationships

The relationship structure for Cardinal Health, Inc. (CAH) in late 2025 centers on tiered service models reflecting the scale and complexity of the customer.

Dedicated account management for large hospital systems and chains

For major customers, the relationship is deeply embedded, often involving multi-year financial agreements. The company extended its Receivables Purchase Agreement, originally dated September 1, 2023, with an amendment executed on September 30, 2025, to extend the facility's maturity date to September 28, 2028. This suggests a commitment to long-term financial and supply chain integration with key lending and banking partners supporting these large relationships.

The impact of large customer contract shifts is evident; for instance, the previously communicated customer contract expiration negatively impacted Fiscal Year 2025 revenue, which was $222.6 billion. However, Q4 revenue increased 21% excluding this expiration, showing the underlying growth with other customers.

High-touch, consultative support for specialty physician practices (MSOs)

Cardinal Health, Inc. (CAH) has aggressively expanded its high-touch support through strategic acquisitions in the Management Services Organization (MSO) space, focusing on providing practice enhancement and administrative services.

  • Acquired majority stake in GI Alliance, a gastroenterology MSO with over 900 physicians.
  • Acquired Integrated Oncology Network (ION), supporting more than 50 practice sites.
  • Announced agreement to acquire Solaris Health, a urology MSO with over 750 providers, for approximately $1.9 billion in cash.
  • The Specialty Networks platform, which includes PPS Analytics, supports over 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices (as of 2024 data).

This consultative approach is supported by technology platforms like PPS Analytics, which leverages real-world data for manufacturer partners and practitioner customers.

Automated and digital self-service for routine pharmacy and clinic orders

For routine transactions, the focus shifts to efficiency through digital tools and logistics optimization. The company continues to build out its logistics capabilities, such as the Consumer Health Logistics Center (CHLC) becoming fully operational in July 2025. Furthermore, OptiFreight Logistics is expanding its offerings within the hospital pharmacy setting to support growth.

The company emphasizes technology and practice management solutions to improve efficiency for specialty practices.

Long-term, contractual relationships for pharmaceutical distribution

The core pharmaceutical distribution business relies on securing and maintaining long-term supply agreements, though the risk of non-renewal is present. The non-renewal of the OptumRx contract, which generated 16% of Fiscal Year 2023 consolidated revenue, was a major event impacting Fiscal Year 2025 results.

Despite this, Cardinal Health, Inc. (CAH) reiterated its long-term segment profit Compound Annual Growth Rate (CAGR) target of 4% to 6% for Pharmaceutical and Specialty Solutions relative to a Fiscal Year 2023 baseline. The company raised its long-term target for this segment profit growth to 5% to 7% normalized growth at its June 2025 Investor Day.

The overall financial performance in Fiscal Year 2025, despite the contract loss, resulted in total operating earnings growth of 15% to $2.8 billion and non-GAAP diluted EPS of $8.24.

Customer Relationship Metric/Segment Focus Associated Financial/Statistical Figure (FY2025 or Relevant Period) Context/Segment
Fiscal Year 2025 Total Revenue $222.6 billion Enterprise-wide, impacted by contract expiration
FY2025 Adjusted Free Cash Flow $2.5 billion Enterprise-wide cash generation
Q4 FY2025 Revenue Excluding Contract Expiration 21% increase Pharmaceutical and Specialty Solutions growth driver
Receivables Purchase Agreement Extension End Date September 28, 2028 Large customer/financial partner relationship term
GI Alliance Physician Count (Acquired in FY2025) Over 900 physicians Specialty Physician Practices (MSO)
Specialty Networks Physician Count (Pre-Acquisitions Context) More than 7,000 physicians Specialty Physician Practices (MSO)
Long-Term PSS Segment Profit Growth Target (Raised FY2025) 5% to 7% normalized growth Pharmaceutical and Specialty Solutions contractual outlook

Cardinal Health, Inc. (CAH) - Canvas Business Model: Channels

You're looking at how Cardinal Health, Inc. gets its products and services to the tens of thousands of locations it serves, from hospitals to homes. It's a massive physical and digital network, so let's look at the hard numbers defining its reach as of late 2025.

Physical distribution centers and warehouses across the U.S.

Cardinal Health, Inc. relies on a vast network of physical infrastructure to move pharmaceuticals and medical products. The company continues to invest heavily in modernizing this footprint. For instance, the At-Home Solutions unit recently opened a new facility in Fort Worth, Texas, equipped with automation technologies. Furthermore, the company announced plans for a new 230,000-square-foot forward distribution hub in Indianapolis, designed with advanced robotics and warehouse automation. This complements the opening of a state-of-the-art consumer-health logistics center, which expanded network capacity by 20%. The At-Home Solutions business also has plans for automation expansion in one existing distribution center and in two new DCs planned for the West and the Northeast.

OptiFreight Logistics for freight management and cost reduction

OptiFreight Logistics, the technology-driven freight-management arm, is a key channel for managing direct shipments. This segment posted $324 million in revenue for fiscal year 2025. The business manages more than 22 million inbound, outbound, and intra-facility shipments annually. These shipments go to over 25,000 shipping locations, including hospitals, pharmacies, labs, and surgery centers. The service is designed to help customers realize significant savings, reporting up to $800 million in customer savings annually. The segment grew more than 20% in the first quarter of fiscal year 2026, building on its 2025 performance.

E-commerce platforms and digital ordering systems for customers

Digital transformation is central to how Cardinal Health, Inc. engages customers across its channels. The company has enhanced e-commerce platforms and upgraded online ordering systems to improve supply chain efficiency and order fulfillment. Artificial intelligence tools are now used within the Pharmaceutical and Specialty Solutions division to improve inventory management and better align supply with pharmacy and hospital needs, cutting delays. The OptiFreight Logistics service uses a cloud-based platform, TotalVue Insights, for tracking, reporting, and analytics, giving customers visibility into their shipping operations.

The digital tools support several key functions:

  • Real-time inventory tracking.
  • Predictive restocking capabilities.
  • Data analytics for supply chain performance.
  • Cloud-based pharmacy management tools.

Specialty Networks and MSO platforms for physician services

Cardinal Health, Inc. is expanding its reach into specialty care through strategic acquisitions that build out its Specialty Alliance platform. The company acquired a majority stake in GI Alliance, a leading gastroenterology MSO, for approximately $2.8 billion in cash. Additionally, the company is advancing its Urology Alliance through recent acquisitions like Urology America. The pending acquisition of Solaris Health is set to add access to more than 750 providers nationwide initially, growing to 3,000 specialty clinicians across 32 states once fully integrated into the Specialty Alliance platform. These MSO platform acquisitions contributed to segment profit growth in the fourth quarter of fiscal 2025.

At-Home Solutions for direct-to-patient medical supplies

The At-Home Solutions division is a direct channel to patients, seeing double-digit revenue growth in the second quarter of fiscal year 2025. This division recorded $3,480 million in revenue for fiscal year 2025. The segment was bolstered by the acquisition of Advanced Diabetes Supply Group (ADSG) for approximately $1.1 billion in cash. This segment serves the rising demand for in-home supplies and chronic care products.

Here is a snapshot of the scale across these key channel components for fiscal year 2025:

Channel Component Metric Value (FY 2025 or Latest Available)
OptiFreight Logistics Revenue $324 million
OptiFreight Logistics Shipments Managed Annually 22 million
At-Home Solutions Revenue $3,480 million
Specialty Networks (Solaris Pending Reach) Specialty Clinicians Access 3,000
Consumer-Health Logistics Network Capacity Expansion 20%
MSO Acquisition (GI Alliance) Cash Consideration $2.8 billion

Finance: draft Q1 FY2026 cash flow projection update by Monday.

Cardinal Health, Inc. (CAH) - Canvas Business Model: Customer Segments

You're looking at the core customer base for Cardinal Health, Inc. as of late 2025, which is heavily weighted toward the institutional side of healthcare delivery. The numbers show a clear focus on large-scale distribution and specialty care enablement.

The largest customer group is served through the Pharmaceutical and Specialty Solutions segment, which generated $204.64 billion in revenue for Fiscal Year 2025, making up 91.91% of the company's total $222.6 billion revenue for the year. This segment is the engine for distribution to pharmacies and health systems.

Here is a breakdown of the key customer groups Cardinal Health, Inc. serves, mapped against their reported segment data:

Customer Segment Group Primary Segment Link FY 2025 Revenue (USD) FY 2025 Revenue Share (Approximate)
Retail and independent pharmacies (core pharmaceutical distribution) Pharmaceutical and Specialty Solutions $204.64 billion 91.91%
Hospitals and Integrated Delivery Networks (IDNs) Pharmaceutical and Specialty Solutions / GMPD $204.64 billion (Pharma) + $12.64 billion (Medical Products) Combined core distribution and medical products
Specialty physician practices (oncology, GI, urology) Pharmaceutical and Specialty Solutions (via MSO platforms/specialty drugs) Included within $204.64 billion Growing contribution via acquisitions like Integrated Oncology Network
Pharmaceutical and medical device manufacturers Global Medical Products and Distribution (GMPD) $12.64 billion 5.67%
Patients requiring at-Home Solutions and nuclear health services Other Segment (at-Home Solutions & Nuclear/Precision Health) $3.480 billion (at-Home) + $1.578 billion (Nuclear) Part of the $5.38 billion Other segment

The customer base for medical products and devices, which often includes hospitals and surgery centers, falls largely under the Global Medical Products and Distribution (GMPD) segment, which posted $12.64 billion in revenue in Fiscal Year 2025.

Cardinal Health, Inc. has actively bolstered its service to specialty practices through strategic investments. For example, the company executed a $1.12 billion acquisition of Integrated Oncology Network to strengthen its cancer care footprint.

The fastest-growing area, which directly serves patients needing specific services, is captured in the Other segment, which reached $5.38 billion in FY2025 revenue. This segment is composed of several distinct customer-facing units:

  • at-Home Solutions revenue was $3.480 billion in FY2025.
  • Nuclear and Precision Health Solutions revenue was $1.578 billion in FY2025.
  • OptiFreight Logistics revenue was $324 million in FY2025.

The company's strategy involves using digital tools to better align supply with the needs of its pharmacy and hospital customers, which is a key part of retaining and serving these large entities.

Cardinal Health, Inc. (CAH) - Canvas Business Model: Cost Structure

You're looking at the major drains on Cardinal Health, Inc.'s bottom line as of late 2025. For a company this size, the costs are massive, and they center around moving product and integrating new, high-value specialty businesses.

High Cost of Goods Sold (COGS) for pharmaceuticals remains the single largest expense category, which is typical for a major distributor. This cost directly reflects the wholesale price paid for the drugs and medical products Cardinal Health, Inc. distributes. For the full fiscal year 2025, the Cost of products sold was reported at $214,410 million, which is a slight decline from the $219,413 million reported in fiscal year 2024. This figure is very close to the total fiscal year 2025 revenue of $222.6 billion, underscoring the thin margins inherent in the distribution business.

The operational side requires significant investment in physical infrastructure. You see substantial operating expenses tied up in logistics, warehousing, and transportation to keep the supply chain moving efficiently. While specific line items for just logistics are hard to isolate, Selling, General, and Administrative (SG&A) expenses give you a sense of the scale. For the three months ended December 31, 2024, SG&A expenses were $1.3 billion, an increase partially driven by the recent acquisitions. The company's structure relies on a vast network, and maintaining that network is a continuous, high-cost endeavor.

Capital expenditures (CapEx) are essential for future efficiency and growth, particularly in automation and facilities upgrades. Cardinal Health, Inc. has committed to a high level of reinvestment here. They expect capital expenditures in fiscal year 2026 to be approximately $600 million, primarily for manufacturing, distribution infrastructure, and technology. This follows capital expenditures of $547 million in fiscal 2025 and $511 million in fiscal 2024. Honestly, planning for at least $600 million annually shows this is a non-negotiable cost of staying competitive.

The recent strategic shift toward specialty services brings new, large-scale costs related to integration. You have to account for the cash outlay for these major purchases, plus the ongoing costs of merging operations. The acquisition of Integrated Oncology Network (ION) was completed in December 2024 for $1.1 billion in cash. Then, the majority stake in GI Alliance (GIA) closed in January 2025 for approximately $2.8 billion in cash, part of a combined $3.9 billion deal that also included Advanced Diabetes Supply Group (ADSG). These transactions are expected to generate transaction and integration costs that can temporarily impact GAAP operating earnings.

The workforce supporting these complex operations represents a major fixed cost. Cardinal Health, Inc. employs a large, specialized staff across distribution, manufacturing, and the newly acquired specialty practice management services. As of the latest available data around September 2025, the company reported having 57.7K employees. That's a specialized workforce that requires significant ongoing investment in compensation and benefits.

Here's a quick look at how some of these key cost and investment figures stack up:

Cost Component Fiscal Year 2025 Amount (or Latest) Fiscal Year 2024 Amount
Cost of Goods Sold (COGS) $214,410 million $219,413 million
Capital Expenditures (CapEx) $547 million $511 million
Projected FY2026 CapEx ~$600 million N/A
ION Acquisition Cost (Cash) $1.1 billion N/A
GI Alliance Majority Stake Cost (Cash) ~$2.8 billion N/A
Total Employees 57.7K N/A

You can see the sheer scale of the COGS relative to revenue, which is the primary cost driver. Also note the significant cash deployment for acquisitions in the recent past, which will translate into integration costs and potentially higher interest expense as debt is used to finance growth.

Cardinal Health, Inc. (CAH) - Canvas Business Model: Revenue Streams

You're looking at the core ways Cardinal Health, Inc. brings in cash as of late 2025. It's heavily weighted toward moving pills and supplies, but the growth story is in the specialty services.

The single largest source of revenue is the distribution of pharmaceuticals. This is the bedrock of the business, though it saw a slight dip year-over-year due to a major contract expiration.

Here's the quick math on the major revenue components for Fiscal Year 2025:

Revenue Stream Component FY2025 Revenue Amount Notes
Pharmaceutical distribution sales (Pharmaceutical Member Segment) $204.64 billion Largest segment, representing about 91.91% of total revenue.
Global Medical Products and Distribution (GMPD) Segment Revenue $12.64 billion Includes sales of Cardinal Health branded medical/surgical products and national brand products.
Other Operating Segments Revenue $5.38 billion Comprises Nuclear and Precision Health Solutions, at-Home Solutions, and OptiFreight Logistics.
OptiFreight Logistics Services Revenue (2025) $324 million Revenue from logistics optimization and transportation management solutions.
Total Fiscal Year 2025 Sales $222.58 billion Total annual revenue for FY2025.

Sales of Cardinal Health Brand medical and surgical products are embedded within the Global Medical Products and Distribution (GMPD) segment revenue of $12.64 billion for FY2025. This segment also handles national brand products for various healthcare providers.

Fees generated from specialty services are a key driver of profit growth, particularly within the Pharmaceutical and Specialty Solutions segment. These revenue sources include:

  • Growth from BioPharma Solutions, which supports pharmaceutical manufacturers for specialty products.
  • Management fees from MSO platforms, such as the contributions from the recently acquired GI Alliance and Integrated Oncology Network.

Revenue from Nuclear and Precision Health Solutions is reported within the 'Other' segment, which totaled $5.38 billion in FY2025. This area focuses on nuclear pharmacies, radiopharmaceutical manufacturing, and expanding capabilities in theranostics for oncology and neurology.

Logistics and freight management services, specifically through OptiFreight Logistics, contributed $324 million in revenue for 2025. This is a component of the 'Other' segment, which saw strong growth, with Q4 revenue for the entire 'Other' category reaching $1.6 billion.

Finance: draft 13-week cash view by Friday.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.